Wietze Lindeboom

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 761 citations

Endovascular Technique, Cardiovascular Disease, Randomised Superiority Trial +8

Intravascular Ultrasound Findings in the Multicenter, Randomized, Double-Blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) Trial

Patrick W. Serruys, Muzaffer Değertekin, Kengo Tanabe et al. · Circulation · 2002 · 354 citations · Full text

Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of Multivessel Coronary Disease Patients

Alexandre Abizaid, Marco A. Costa, Marinella Centemero et al. · Circulation · 2001 · 340 citations · Full text

Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease

Carlos Collet, Yoshinobu Onuma, Daniele Andreini et al. · European Heart Journal · 2018 · 242 citations · Full text

Three-Year Outcome After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease

Victor Legrand, Patrick W. Serruys, Felix Unger et al. · Circulation · 2004 · 223 citations